Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
CB Wiedenroth, C Liebetrau, A Breithecker… - The Journal of Heart and …, 2016 - Elsevier
Background Pulmonary endarterectomy (PEA) is a curative treatment option for more than
60% of patients with chronic thromboembolic pulmonary hypertension (CTEPH). For
selected inoperable patients, interventional balloon pulmonary angioplasty (BPA) has
recently been established in addition to medical treatment. This approach disrupts scar
tissue occluding the pulmonary arteries, leading to an improvement in parenchymal
perfusion. CTEPH is occasionally heterogeneous, with operable disease on one side but …
60% of patients with chronic thromboembolic pulmonary hypertension (CTEPH). For
selected inoperable patients, interventional balloon pulmonary angioplasty (BPA) has
recently been established in addition to medical treatment. This approach disrupts scar
tissue occluding the pulmonary arteries, leading to an improvement in parenchymal
perfusion. CTEPH is occasionally heterogeneous, with operable disease on one side but …
以上显示的是最相近的搜索结果。 查看全部搜索结果